Acibadem Healthcare Group
FERHAT DEMİR
Assoc. Prof. M.D.

FERHAT DEMİR

Medical Units and Clinical Services
  • Pediatric Rheumatology
  • Pediatrics

Assoc. Prof. Ferhat Demir is a pediatric rheumatologist with specialized training from Karadeniz Technical University Faculty of Medicine, completing his Pediatric Rheumatology training in 2018. He currently practices at Acibadem Health Group, where he provides care for children and adolescents with rheumatic and autoimmune conditions. M.D. Demir is an active member of professional societies including the Turkish Society of Pediatric Rheumatology and the European Society of Pediatric Rheumatology. He is committed to delivering evidence-based, compassionate care and to staying current with advances in pediatric rheumatology to improve outcomes for his patients.

Education

  • 2018 Karadeniz Technical University Faculty of Medicine Pediatric Rheumatology
  • 2016 Pediatric Rheumatology International Trial Organisation (PRINTO),Pediatric Rheumatology, Pediatria II, Pediatria Rheumatologia, Malattie Rare, Gaslini, Genova, Italy / Fellowsip
  • 2014 Kanuni Sultan Süleyman Training and Research Hospital Pediatrics
  • 2009 Istanbul University Cerrahpasa Faculty of Medicine

Experience

  • 2021 Acibadem Health Group
  • 2018 – 2021 Ümraniye Training and Research Hospital / Pediatric Rheumatology Specialist
  • 2015 – 2018 Karadeniz Technical University / Division of Pediatric Rheumatology / Pediatric Rheumatology Assistant
  • 2014 – 2015 Sanliurfa Hospital for Pediatrics, Sanliurfa / Pediatrics Specialist
  • 2011 – 2014 Kanuni Sultan Suleyman Training and Research Hospital, Istanbul
  • 2009 – 2014 Pediatrics Assistant
  • 2009 – 2011 Bakirkoy Yenimahalle Maternity and Pediatrics Hospital

Memberships

  • Turkish Society of Pediatric Rheumatology
  • European Society of Pediatric Rheumatology

Publications

  • Drug survival of the infliximab biosimilar (CT-P13) in paediatric patients with non-infectious uveitis.
    Clin Exp Rheumatol. 2021 Feb 9. Sözeri B, Kardeş E, Salı E, Çakır D, Demir F.
  • Clinical course of COVID-19 in children with rheumatic disease under biologic therapy
    Clin Exp Rheumatol. 2021 Jan-Feb;39 Demir F, Ulu K, Caglayan S, Coskuner T, Sozeri B.
  • Hepatitis B vaccination response of treatment-naive patients with juvenile idiopathic arthritis.
    Rheumatol Int. 2021 Mar 18. doi: 10.1007/s00296-021-04833-3. Çakmak F, Çakan M, Demir F, Sönmez HE, Çakmak S, Demîrkan FG, Karadağ ŞG, Ayaz NA, Sözeri B.
  • Comparison of the clinical diagnostic criteria and the results of the next-generation sequence gene panel in patients with monogenic systemic autoinflammatory diseases
    Clin Rheumatol. 2021 Jun;40(6):2327-2337. doi: 10.1007/SI0067-020-05492-8. Sözeri B, Demir F, Sönmez HE, Karadağ ŞG, Demirkol YK, Doğan ÖA, Doğanay HL, Ayaz NA.
  • Adherence to best practice consensus guidelines for familial Mediterranean fever: a modified Delphi study among paediatric rheumatologists in Turkey
    Eker Omeroglu R, Aktay Ayaz N; PeRA-Research Group. Rheumatol Int. 2021 Jan 16:1-8. doi: 10.1007/s00296-020-04776-l. Kavrul Kayaalp G, Sözeri B, Sönmez HE, Demir F, Cakan M, Oztürk K, Karadağ SG, Otar Yener G, Ozdel S, Bağlan E, Celikel E, Şahin N, Gezgin Yildirim D,
  • Hematological involvement in pediatric systemic lupus erythematosus: A multi-center study
    Lupus. 2021 May 6:9612033211014271. doi: 10.1177/09612033211014271. K Akça Ü, Batu ED, Kısaarslan AP, Poyrazoğlu H, Ayaz NA, Sözeri B, Sağ E, Atalay E, Demir S, Karadağ ŞG, Demir F, Bilginer Y, Gümrük F, Özen S.
  • Time to collaborate: Objectives, design, and methodology of PeRA-Research Group.
    North Clin Istanb. 2021 Feb 25;8(2):200-202. doi: 10.14744/nci.2020.25826. Sözeri B, Emine Sonmez H, Demir F, Cakan M, Ozturk K, Ozdel S, Otar Yener G, Gul Karadag S, Aktay Ayaz N.
  • Neuroimaging of Children With Takayasu Arteritis.
    J Child Neurol. 2021 Feb 16:883073821991287. doi: 10.1177/0883073821991287. Sönmez HE, Demir F, Özdel S, Karadağ ŞG, Bağlan E, Bülbül M, Çakan M, Ayaz NA, Sözeri B.
  • Plasma microRNA levels in childhood IgA vasculitis
    CLINICAL RHEUMATOLOGY, Doi: 10.1007/sl0067-020- 05441-5 (2020) ÇEBI ALPER HAN,DEMİR FERHAT,İkbal Mevlit,KALYONCU MUKADDES
  • A striking treatment option for recalcitrant calcinosis in juvenile dermatomyocystis: tofatinibe citrate.
    RHEUMATOLOGY, Doi:l 0.1093/rheumatolog y/keaa360 (2020) Sözeri Betül,Demir Ferhat




×
Logo

29 hospitals and 15 medical centers in 5 countries.

About Us
Hospitals
Treatments
Doctors
Medical Technologies
Check Up Packages
Appointment
Blog
Health Library
Contact Us
Promotional
About Us

At ACIBADEM Healthcare Group, we are committed to healthcare excellence and providing world-class healthcare services to our patients. As a leader in international healthcare, we strive to deliver the highest quality of care and meet the needs of our diverse patient population.

Read More...
Appointment FormLive Support
Manage your privacy

We use technologies like cookies to store and/or access device information. We do this to improve browsing experience and to show (non-) personalized ads. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional
Always active
Preferences
Statistics